nodes	percent_of_prediction	percent_of_DWPC	metapath
Citalopram—CYP1A2—Carmustine—lymphatic system cancer	0.124	0.221	CbGbCtD
Citalopram—CYP2E1—Mitoxantrone—lymphatic system cancer	0.1	0.179	CbGbCtD
Citalopram—CYP2C19—Teniposide—lymphatic system cancer	0.09	0.161	CbGbCtD
Citalopram—ABCB1—Mitoxantrone—lymphatic system cancer	0.0508	0.0907	CbGbCtD
Citalopram—CYP3A4—Cytarabine—lymphatic system cancer	0.0442	0.0789	CbGbCtD
Citalopram—CYP3A4—Teniposide—lymphatic system cancer	0.0435	0.0777	CbGbCtD
Citalopram—ABCB1—Vincristine—lymphatic system cancer	0.035	0.0624	CbGbCtD
Citalopram—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0304	0.0543	CbGbCtD
Citalopram—ABCB1—Methotrexate—lymphatic system cancer	0.0212	0.0378	CbGbCtD
Citalopram—CYP3A4—Vincristine—lymphatic system cancer	0.0209	0.0374	CbGbCtD
Citalopram—Rash—Teniposide—lymphatic system cancer	0.000318	0.000724	CcSEcCtD
Citalopram—Dermatitis—Teniposide—lymphatic system cancer	0.000318	0.000723	CcSEcCtD
Citalopram—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000317	0.00072	CcSEcCtD
Citalopram—Headache—Teniposide—lymphatic system cancer	0.000316	0.000719	CcSEcCtD
Citalopram—Pruritus—Fludarabine—lymphatic system cancer	0.000314	0.000714	CcSEcCtD
Citalopram—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.000314	0.000713	CcSEcCtD
Citalopram—Back pain—Mitoxantrone—lymphatic system cancer	0.000313	0.000711	CcSEcCtD
Citalopram—Leukopenia—Carmustine—lymphatic system cancer	0.000312	0.000708	CcSEcCtD
Citalopram—Anorexia—Bleomycin—lymphatic system cancer	0.00031	0.000705	CcSEcCtD
Citalopram—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.000308	0.0007	CcSEcCtD
Citalopram—Anaemia—Vincristine—lymphatic system cancer	0.000307	0.000698	CcSEcCtD
Citalopram—Agitation—Vincristine—lymphatic system cancer	0.000305	0.000694	CcSEcCtD
Citalopram—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000305	0.000693	CcSEcCtD
Citalopram—Polyuria—Methotrexate—lymphatic system cancer	0.000305	0.000693	CcSEcCtD
Citalopram—Hypotension—Bleomycin—lymphatic system cancer	0.000304	0.000691	CcSEcCtD
Citalopram—Diarrhoea—Fludarabine—lymphatic system cancer	0.000304	0.00069	CcSEcCtD
Citalopram—Convulsion—Carmustine—lymphatic system cancer	0.000302	0.000685	CcSEcCtD
Citalopram—Hypertension—Carmustine—lymphatic system cancer	0.000301	0.000683	CcSEcCtD
Citalopram—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.0003	0.000682	CcSEcCtD
Citalopram—Nausea—Teniposide—lymphatic system cancer	0.0003	0.000682	CcSEcCtD
Citalopram—Anaemia—Mitoxantrone—lymphatic system cancer	0.000299	0.00068	CcSEcCtD
Citalopram—Vertigo—Vincristine—lymphatic system cancer	0.000299	0.000678	CcSEcCtD
Citalopram—Hepatic failure—Methotrexate—lymphatic system cancer	0.000298	0.000677	CcSEcCtD
Citalopram—Leukopenia—Vincristine—lymphatic system cancer	0.000297	0.000676	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000297	0.000674	CcSEcCtD
Citalopram—Chest pain—Carmustine—lymphatic system cancer	0.000296	0.000673	CcSEcCtD
Citalopram—Myalgia—Carmustine—lymphatic system cancer	0.000296	0.000673	CcSEcCtD
Citalopram—Anxiety—Carmustine—lymphatic system cancer	0.000295	0.000671	CcSEcCtD
Citalopram—Paraesthesia—Bleomycin—lymphatic system cancer	0.000292	0.000664	CcSEcCtD
Citalopram—Malaise—Mitoxantrone—lymphatic system cancer	0.000292	0.000663	CcSEcCtD
Citalopram—Dyspnoea—Bleomycin—lymphatic system cancer	0.00029	0.000659	CcSEcCtD
Citalopram—Renal failure acute—Methotrexate—lymphatic system cancer	0.00029	0.000659	CcSEcCtD
Citalopram—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00029	0.000658	CcSEcCtD
Citalopram—Convulsion—Vincristine—lymphatic system cancer	0.000288	0.000654	CcSEcCtD
Citalopram—Hypertension—Vincristine—lymphatic system cancer	0.000287	0.000652	CcSEcCtD
Citalopram—Confusional state—Carmustine—lymphatic system cancer	0.000286	0.000651	CcSEcCtD
Citalopram—Oedema—Carmustine—lymphatic system cancer	0.000284	0.000646	CcSEcCtD
Citalopram—Decreased appetite—Bleomycin—lymphatic system cancer	0.000283	0.000643	CcSEcCtD
Citalopram—Myalgia—Vincristine—lymphatic system cancer	0.000283	0.000643	CcSEcCtD
Citalopram—Visual disturbance—Methotrexate—lymphatic system cancer	0.000283	0.000642	CcSEcCtD
Citalopram—Cough—Mitoxantrone—lymphatic system cancer	0.000282	0.000642	CcSEcCtD
Citalopram—Infection—Carmustine—lymphatic system cancer	0.000282	0.000641	CcSEcCtD
Citalopram—Vomiting—Fludarabine—lymphatic system cancer	0.000282	0.000641	CcSEcCtD
Citalopram—Convulsion—Mitoxantrone—lymphatic system cancer	0.00028	0.000637	CcSEcCtD
Citalopram—Rash—Fludarabine—lymphatic system cancer	0.00028	0.000636	CcSEcCtD
Citalopram—Dermatitis—Fludarabine—lymphatic system cancer	0.00028	0.000635	CcSEcCtD
Citalopram—Hypertension—Mitoxantrone—lymphatic system cancer	0.000279	0.000635	CcSEcCtD
Citalopram—Pain—Bleomycin—lymphatic system cancer	0.000278	0.000632	CcSEcCtD
Citalopram—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000278	0.000632	CcSEcCtD
Citalopram—Headache—Fludarabine—lymphatic system cancer	0.000278	0.000632	CcSEcCtD
Citalopram—Tachycardia—Carmustine—lymphatic system cancer	0.000277	0.00063	CcSEcCtD
Citalopram—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000276	0.000626	CcSEcCtD
Citalopram—Chest pain—Mitoxantrone—lymphatic system cancer	0.000276	0.000626	CcSEcCtD
Citalopram—Myalgia—Mitoxantrone—lymphatic system cancer	0.000276	0.000626	CcSEcCtD
Citalopram—Anxiety—Mitoxantrone—lymphatic system cancer	0.000275	0.000624	CcSEcCtD
Citalopram—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.000273	0.000621	CcSEcCtD
Citalopram—Lethargy—Methotrexate—lymphatic system cancer	0.000273	0.000621	CcSEcCtD
Citalopram—Discomfort—Mitoxantrone—lymphatic system cancer	0.000272	0.000619	CcSEcCtD
Citalopram—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000271	0.000616	CcSEcCtD
Citalopram—Oedema—Vincristine—lymphatic system cancer	0.000271	0.000616	CcSEcCtD
Citalopram—Anorexia—Carmustine—lymphatic system cancer	0.000271	0.000615	CcSEcCtD
Citalopram—Infection—Vincristine—lymphatic system cancer	0.000269	0.000612	CcSEcCtD
Citalopram—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000268	0.00061	CcSEcCtD
Citalopram—Osteoarthritis—Methotrexate—lymphatic system cancer	0.000268	0.000608	CcSEcCtD
Citalopram—Confusional state—Mitoxantrone—lymphatic system cancer	0.000266	0.000605	CcSEcCtD
Citalopram—Nervous system disorder—Vincristine—lymphatic system cancer	0.000266	0.000604	CcSEcCtD
Citalopram—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000266	0.000603	CcSEcCtD
Citalopram—Hypotension—Carmustine—lymphatic system cancer	0.000265	0.000603	CcSEcCtD
Citalopram—Oedema—Mitoxantrone—lymphatic system cancer	0.000264	0.0006	CcSEcCtD
Citalopram—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000264	0.0006	CcSEcCtD
Citalopram—Nausea—Fludarabine—lymphatic system cancer	0.000264	0.000599	CcSEcCtD
Citalopram—Infection—Mitoxantrone—lymphatic system cancer	0.000262	0.000596	CcSEcCtD
Citalopram—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000262	0.000596	CcSEcCtD
Citalopram—Shock—Mitoxantrone—lymphatic system cancer	0.00026	0.000591	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000259	0.000588	CcSEcCtD
Citalopram—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000259	0.000588	CcSEcCtD
Citalopram—Urticaria—Bleomycin—lymphatic system cancer	0.000259	0.000588	CcSEcCtD
Citalopram—Anorexia—Vincristine—lymphatic system cancer	0.000259	0.000587	CcSEcCtD
Citalopram—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000258	0.000586	CcSEcCtD
Citalopram—Body temperature increased—Bleomycin—lymphatic system cancer	0.000257	0.000585	CcSEcCtD
Citalopram—Insomnia—Carmustine—lymphatic system cancer	0.000257	0.000584	CcSEcCtD
Citalopram—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000257	0.000583	CcSEcCtD
Citalopram—Irritability—Methotrexate—lymphatic system cancer	0.000256	0.000581	CcSEcCtD
Citalopram—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000255	0.00058	CcSEcCtD
Citalopram—Paraesthesia—Carmustine—lymphatic system cancer	0.000255	0.00058	CcSEcCtD
Citalopram—Mood swings—Methotrexate—lymphatic system cancer	0.000254	0.000576	CcSEcCtD
Citalopram—Hypotension—Vincristine—lymphatic system cancer	0.000253	0.000576	CcSEcCtD
Citalopram—Dyspnoea—Carmustine—lymphatic system cancer	0.000253	0.000576	CcSEcCtD
Citalopram—Somnolence—Carmustine—lymphatic system cancer	0.000253	0.000574	CcSEcCtD
Citalopram—Anorexia—Mitoxantrone—lymphatic system cancer	0.000252	0.000572	CcSEcCtD
Citalopram—Ataxia—Methotrexate—lymphatic system cancer	0.000252	0.000572	CcSEcCtD
Citalopram—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000247	0.000562	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000247	0.000562	CcSEcCtD
Citalopram—Decreased appetite—Carmustine—lymphatic system cancer	0.000247	0.000561	CcSEcCtD
Citalopram—Hypotension—Mitoxantrone—lymphatic system cancer	0.000247	0.000561	CcSEcCtD
Citalopram—Insomnia—Vincristine—lymphatic system cancer	0.000245	0.000557	CcSEcCtD
Citalopram—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000245	0.000557	CcSEcCtD
Citalopram—Paraesthesia—Vincristine—lymphatic system cancer	0.000244	0.000553	CcSEcCtD
Citalopram—Pain—Carmustine—lymphatic system cancer	0.000243	0.000552	CcSEcCtD
Citalopram—Constipation—Carmustine—lymphatic system cancer	0.000243	0.000552	CcSEcCtD
Citalopram—Breast disorder—Methotrexate—lymphatic system cancer	0.000242	0.00055	CcSEcCtD
Citalopram—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.000241	0.000548	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000241	0.000547	CcSEcCtD
Citalopram—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00024	0.000545	CcSEcCtD
Citalopram—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000237	0.000539	CcSEcCtD
Citalopram—Decreased appetite—Vincristine—lymphatic system cancer	0.000236	0.000536	CcSEcCtD
Citalopram—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000235	0.000535	CcSEcCtD
Citalopram—Somnolence—Mitoxantrone—lymphatic system cancer	0.000235	0.000534	CcSEcCtD
Citalopram—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000234	0.000532	CcSEcCtD
Citalopram—Feeling abnormal—Carmustine—lymphatic system cancer	0.000234	0.000532	CcSEcCtD
Citalopram—Fatigue—Vincristine—lymphatic system cancer	0.000234	0.000531	CcSEcCtD
Citalopram—Asthenia—Bleomycin—lymphatic system cancer	0.000234	0.000531	CcSEcCtD
Citalopram—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000233	0.000528	CcSEcCtD
Citalopram—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000232	0.000528	CcSEcCtD
Citalopram—Pain—Vincristine—lymphatic system cancer	0.000232	0.000527	CcSEcCtD
Citalopram—Constipation—Vincristine—lymphatic system cancer	0.000232	0.000527	CcSEcCtD
Citalopram—Asthma—Methotrexate—lymphatic system cancer	0.000231	0.000526	CcSEcCtD
Citalopram—Pruritus—Bleomycin—lymphatic system cancer	0.00023	0.000523	CcSEcCtD
Citalopram—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00023	0.000522	CcSEcCtD
Citalopram—Eosinophilia—Methotrexate—lymphatic system cancer	0.000229	0.000521	CcSEcCtD
Citalopram—Fatigue—Mitoxantrone—lymphatic system cancer	0.000228	0.000517	CcSEcCtD
Citalopram—Pancreatitis—Methotrexate—lymphatic system cancer	0.000227	0.000516	CcSEcCtD
Citalopram—Pain—Mitoxantrone—lymphatic system cancer	0.000226	0.000513	CcSEcCtD
Citalopram—Constipation—Mitoxantrone—lymphatic system cancer	0.000226	0.000513	CcSEcCtD
Citalopram—Abdominal pain—Carmustine—lymphatic system cancer	0.000225	0.00051	CcSEcCtD
Citalopram—Body temperature increased—Carmustine—lymphatic system cancer	0.000225	0.00051	CcSEcCtD
Citalopram—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.000222	0.000504	CcSEcCtD
Citalopram—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000222	0.000504	CcSEcCtD
Citalopram—Pancytopenia—Methotrexate—lymphatic system cancer	0.00022	0.000499	CcSEcCtD
Citalopram—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000218	0.000495	CcSEcCtD
Citalopram—Dysuria—Methotrexate—lymphatic system cancer	0.000216	0.000492	CcSEcCtD
Citalopram—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000216	0.000491	CcSEcCtD
Citalopram—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000215	0.000489	CcSEcCtD
Citalopram—Body temperature increased—Vincristine—lymphatic system cancer	0.000214	0.000487	CcSEcCtD
Citalopram—Abdominal pain—Vincristine—lymphatic system cancer	0.000214	0.000487	CcSEcCtD
Citalopram—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000213	0.000484	CcSEcCtD
Citalopram—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000211	0.00048	CcSEcCtD
Citalopram—Urticaria—Mitoxantrone—lymphatic system cancer	0.00021	0.000477	CcSEcCtD
Citalopram—Hypersensitivity—Carmustine—lymphatic system cancer	0.000209	0.000476	CcSEcCtD
Citalopram—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000209	0.000474	CcSEcCtD
Citalopram—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000209	0.000474	CcSEcCtD
Citalopram—Pneumonia—Methotrexate—lymphatic system cancer	0.000208	0.000472	CcSEcCtD
Citalopram—Vomiting—Bleomycin—lymphatic system cancer	0.000207	0.00047	CcSEcCtD
Citalopram—Infestation NOS—Methotrexate—lymphatic system cancer	0.000206	0.000469	CcSEcCtD
Citalopram—Infestation—Methotrexate—lymphatic system cancer	0.000206	0.000469	CcSEcCtD
Citalopram—Depression—Methotrexate—lymphatic system cancer	0.000206	0.000468	CcSEcCtD
Citalopram—Rash—Bleomycin—lymphatic system cancer	0.000205	0.000466	CcSEcCtD
Citalopram—Dermatitis—Bleomycin—lymphatic system cancer	0.000205	0.000466	CcSEcCtD
Citalopram—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000205	0.000465	CcSEcCtD
Citalopram—Asthenia—Carmustine—lymphatic system cancer	0.000204	0.000463	CcSEcCtD
Citalopram—Stomatitis—Methotrexate—lymphatic system cancer	0.000201	0.000457	CcSEcCtD
Citalopram—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000201	0.000456	CcSEcCtD
Citalopram—Hypersensitivity—Vincristine—lymphatic system cancer	0.0002	0.000454	CcSEcCtD
Citalopram—Sweating—Methotrexate—lymphatic system cancer	0.000198	0.00045	CcSEcCtD
Citalopram—Haematuria—Methotrexate—lymphatic system cancer	0.000197	0.000447	CcSEcCtD
Citalopram—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000195	0.000443	CcSEcCtD
Citalopram—Epistaxis—Methotrexate—lymphatic system cancer	0.000195	0.000442	CcSEcCtD
Citalopram—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000195	0.000442	CcSEcCtD
Citalopram—Asthenia—Vincristine—lymphatic system cancer	0.000195	0.000442	CcSEcCtD
Citalopram—Diarrhoea—Carmustine—lymphatic system cancer	0.000194	0.000442	CcSEcCtD
Citalopram—Nausea—Bleomycin—lymphatic system cancer	0.000193	0.000439	CcSEcCtD
Citalopram—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000193	0.000438	CcSEcCtD
Citalopram—Asthenia—Mitoxantrone—lymphatic system cancer	0.00019	0.000431	CcSEcCtD
Citalopram—Dizziness—Carmustine—lymphatic system cancer	0.000188	0.000427	CcSEcCtD
Citalopram—Haemoglobin—Methotrexate—lymphatic system cancer	0.000186	0.000423	CcSEcCtD
Citalopram—Diarrhoea—Vincristine—lymphatic system cancer	0.000186	0.000422	CcSEcCtD
Citalopram—Hepatitis—Methotrexate—lymphatic system cancer	0.000185	0.000421	CcSEcCtD
Citalopram—Haemorrhage—Methotrexate—lymphatic system cancer	0.000185	0.000421	CcSEcCtD
Citalopram—Pharyngitis—Methotrexate—lymphatic system cancer	0.000184	0.000418	CcSEcCtD
Citalopram—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000183	0.000416	CcSEcCtD
Citalopram—Urethral disorder—Methotrexate—lymphatic system cancer	0.000182	0.000413	CcSEcCtD
Citalopram—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000181	0.000411	CcSEcCtD
Citalopram—Vomiting—Carmustine—lymphatic system cancer	0.000181	0.00041	CcSEcCtD
Citalopram—Dizziness—Vincristine—lymphatic system cancer	0.000179	0.000408	CcSEcCtD
Citalopram—Rash—Carmustine—lymphatic system cancer	0.000179	0.000407	CcSEcCtD
Citalopram—Dermatitis—Carmustine—lymphatic system cancer	0.000179	0.000407	CcSEcCtD
Citalopram—Visual impairment—Methotrexate—lymphatic system cancer	0.000179	0.000406	CcSEcCtD
Citalopram—Headache—Carmustine—lymphatic system cancer	0.000178	0.000404	CcSEcCtD
Citalopram—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000175	0.000398	CcSEcCtD
Citalopram—Eye disorder—Methotrexate—lymphatic system cancer	0.000173	0.000393	CcSEcCtD
Citalopram—Tinnitus—Methotrexate—lymphatic system cancer	0.000173	0.000392	CcSEcCtD
Citalopram—Vomiting—Vincristine—lymphatic system cancer	0.000172	0.000392	CcSEcCtD
Citalopram—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000172	0.000391	CcSEcCtD
Citalopram—Rash—Vincristine—lymphatic system cancer	0.000171	0.000389	CcSEcCtD
Citalopram—Dermatitis—Vincristine—lymphatic system cancer	0.000171	0.000388	CcSEcCtD
Citalopram—Headache—Vincristine—lymphatic system cancer	0.00017	0.000386	CcSEcCtD
Citalopram—Nausea—Carmustine—lymphatic system cancer	0.000169	0.000383	CcSEcCtD
Citalopram—Angiopathy—Methotrexate—lymphatic system cancer	0.000168	0.000382	CcSEcCtD
Citalopram—Vomiting—Mitoxantrone—lymphatic system cancer	0.000168	0.000382	CcSEcCtD
Citalopram—Immune system disorder—Methotrexate—lymphatic system cancer	0.000167	0.00038	CcSEcCtD
Citalopram—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000167	0.000379	CcSEcCtD
Citalopram—Rash—Mitoxantrone—lymphatic system cancer	0.000167	0.000378	CcSEcCtD
Citalopram—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000166	0.000378	CcSEcCtD
Citalopram—Chills—Methotrexate—lymphatic system cancer	0.000166	0.000378	CcSEcCtD
Citalopram—Headache—Mitoxantrone—lymphatic system cancer	0.000165	0.000376	CcSEcCtD
Citalopram—Alopecia—Methotrexate—lymphatic system cancer	0.000164	0.000372	CcSEcCtD
Citalopram—Mental disorder—Methotrexate—lymphatic system cancer	0.000162	0.000369	CcSEcCtD
Citalopram—Malnutrition—Methotrexate—lymphatic system cancer	0.000161	0.000366	CcSEcCtD
Citalopram—Erythema—Methotrexate—lymphatic system cancer	0.000161	0.000366	CcSEcCtD
Citalopram—Nausea—Vincristine—lymphatic system cancer	0.000161	0.000366	CcSEcCtD
Citalopram—Dysgeusia—Methotrexate—lymphatic system cancer	0.000158	0.000359	CcSEcCtD
Citalopram—Nausea—Mitoxantrone—lymphatic system cancer	0.000157	0.000357	CcSEcCtD
Citalopram—Back pain—Methotrexate—lymphatic system cancer	0.000156	0.000354	CcSEcCtD
Citalopram—Vision blurred—Methotrexate—lymphatic system cancer	0.000152	0.000345	CcSEcCtD
Citalopram—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00015	0.00034	CcSEcCtD
Citalopram—Anaemia—Methotrexate—lymphatic system cancer	0.000149	0.000339	CcSEcCtD
Citalopram—Malaise—Methotrexate—lymphatic system cancer	0.000145	0.00033	CcSEcCtD
Citalopram—Vertigo—Methotrexate—lymphatic system cancer	0.000145	0.000329	CcSEcCtD
Citalopram—Leukopenia—Methotrexate—lymphatic system cancer	0.000144	0.000328	CcSEcCtD
Citalopram—Cough—Methotrexate—lymphatic system cancer	0.000141	0.00032	CcSEcCtD
Citalopram—Convulsion—Methotrexate—lymphatic system cancer	0.00014	0.000317	CcSEcCtD
Citalopram—Chest pain—Methotrexate—lymphatic system cancer	0.000137	0.000312	CcSEcCtD
Citalopram—Myalgia—Methotrexate—lymphatic system cancer	0.000137	0.000312	CcSEcCtD
Citalopram—Arthralgia—Methotrexate—lymphatic system cancer	0.000137	0.000312	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000136	0.00031	CcSEcCtD
Citalopram—Discomfort—Methotrexate—lymphatic system cancer	0.000136	0.000308	CcSEcCtD
Citalopram—Confusional state—Methotrexate—lymphatic system cancer	0.000133	0.000302	CcSEcCtD
Citalopram—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000132	0.000299	CcSEcCtD
Citalopram—Infection—Methotrexate—lymphatic system cancer	0.000131	0.000297	CcSEcCtD
Citalopram—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000129	0.000293	CcSEcCtD
Citalopram—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000129	0.000293	CcSEcCtD
Citalopram—Skin disorder—Methotrexate—lymphatic system cancer	0.000128	0.00029	CcSEcCtD
Citalopram—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000127	0.000289	CcSEcCtD
Citalopram—Anorexia—Methotrexate—lymphatic system cancer	0.000125	0.000285	CcSEcCtD
Citalopram—Hypotension—Methotrexate—lymphatic system cancer	0.000123	0.000279	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.00012	0.000272	CcSEcCtD
Citalopram—Insomnia—Methotrexate—lymphatic system cancer	0.000119	0.00027	CcSEcCtD
Citalopram—Paraesthesia—Methotrexate—lymphatic system cancer	0.000118	0.000269	CcSEcCtD
Citalopram—Dyspnoea—Methotrexate—lymphatic system cancer	0.000117	0.000267	CcSEcCtD
Citalopram—Somnolence—Methotrexate—lymphatic system cancer	0.000117	0.000266	CcSEcCtD
Citalopram—Dyspepsia—Methotrexate—lymphatic system cancer	0.000116	0.000263	CcSEcCtD
Citalopram—Decreased appetite—Methotrexate—lymphatic system cancer	0.000114	0.00026	CcSEcCtD
Citalopram—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000114	0.000258	CcSEcCtD
Citalopram—Fatigue—Methotrexate—lymphatic system cancer	0.000113	0.000258	CcSEcCtD
Citalopram—Pain—Methotrexate—lymphatic system cancer	0.000113	0.000256	CcSEcCtD
Citalopram—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000108	0.000246	CcSEcCtD
Citalopram—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000108	0.000245	CcSEcCtD
Citalopram—Urticaria—Methotrexate—lymphatic system cancer	0.000105	0.000238	CcSEcCtD
Citalopram—Body temperature increased—Methotrexate—lymphatic system cancer	0.000104	0.000236	CcSEcCtD
Citalopram—Abdominal pain—Methotrexate—lymphatic system cancer	0.000104	0.000236	CcSEcCtD
Citalopram—Hypersensitivity—Methotrexate—lymphatic system cancer	9.7e-05	0.00022	CcSEcCtD
Citalopram—Asthenia—Methotrexate—lymphatic system cancer	9.44e-05	0.000215	CcSEcCtD
Citalopram—Pruritus—Methotrexate—lymphatic system cancer	9.31e-05	0.000212	CcSEcCtD
Citalopram—Diarrhoea—Methotrexate—lymphatic system cancer	9e-05	0.000205	CcSEcCtD
Citalopram—Dizziness—Methotrexate—lymphatic system cancer	8.7e-05	0.000198	CcSEcCtD
Citalopram—Vomiting—Methotrexate—lymphatic system cancer	8.37e-05	0.00019	CcSEcCtD
Citalopram—Rash—Methotrexate—lymphatic system cancer	8.3e-05	0.000189	CcSEcCtD
Citalopram—Dermatitis—Methotrexate—lymphatic system cancer	8.29e-05	0.000188	CcSEcCtD
Citalopram—Headache—Methotrexate—lymphatic system cancer	8.24e-05	0.000187	CcSEcCtD
Citalopram—Nausea—Methotrexate—lymphatic system cancer	7.82e-05	0.000178	CcSEcCtD
